ICCC · Immucell Corp · Documents

Dec 2

Current report 8-K Events of Nov 29

Entered into a material agreement

Nov 13

Earnings call

Q3 2024 earnings call

Nov 13

Current report 8-K

Financial results

Nov 13

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $6.01M ▲ 11.4% Net loss $701.69K Diluted EPS -$0.09

Oct 8

Current report 8-K

Financial results

Sep 24

Current report 8-K Events of Sep 20

Entered into a material agreement, New debt or off-balance-sheet obligation, Charter or bylaw amendment, or fiscal year change

Aug 13

Earnings call

Q2 2024 earnings call

Aug 13

Current report 8-K

Financial results

Aug 13

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $5.47M ▲ 54.9% Net loss $1.53M Diluted EPS -$0.20

Jul 9

Current report 8-K

Financial results

Jun 14

Current report 8-K Events of Jun 13

Shareholder vote results

Jun 14

Current report 8-K Events of Jun 11

Entered into a material agreement, New debt or off-balance-sheet obligation

Jun 6

Current report 8-K Events of Jun 5

Other events

May 14

Current report 8-K

Financial results

May 14

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $7.26M ▲ 110.6% Net loss $437.87K Diluted EPS -$0.06

Apr 26

Proxy statement DEF 14A Meeting Jun 13, 2024

Proxy statement

Apr 9

Earnings call

Q1 2024 earnings call

Apr 9

Current report 8-K

Financial results

Apr 9

Current report 8-K Events of Apr 8

Entered into a material agreement

Apr 1

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $17.47M ▼ 5.9% Net loss $5.77M Diluted EPS -$0.75

Apr 1

Registration statement S-3

Registration statement

Mar 6

Current report 8-K Events of Mar 4

Entered into a material agreement

Feb 27

Earnings call

Q4 2023 earnings call

Feb 27

Current report 8-K

Financial results

Feb 27

Current report 8-K Events of Feb 22

Entered into a material agreement, New debt or off-balance-sheet obligation

Jan 8

Current report 8-K

Financial results

Nov 16

Current report 8-K Events of Nov 14

Entered into a material agreement, New debt or off-balance-sheet obligation

Nov 13

Current report 8-K

Financial results

Nov 13

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $5.4M ▲ 12.5% Net loss $940K Diluted EPS -$0.12

Oct 5

Earnings call

Q3 2023 earnings call

Oct 5

Current report 8-K

Financial results

Aug 10

Earnings call

Q2 2023 earnings call

Aug 10

Current report 8-K

Financial results

Aug 10

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $3.53M ▼ 8.5% Net loss $1.38M Diluted EPS -$0.18

Jul 21

Current report 8-K Events of Jul 17

Entered into a material agreement, New debt or off-balance-sheet obligation

Jul 11

Current report 8-K

Financial results

Jun 29

Current report 8-K Events of Jun 28

Regulation FD disclosure

Jun 21

Current report 8-K Events of Jun 15

Director or officer change, or executive pay, Shareholder vote results

May 11

Current report 8-K

Financial results

May 11

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $3.45M ▼ 42.6% Net loss $2.32M Diluted EPS -$0.30

Apr 28

Proxy statement DEF 14A Meeting Jun 15, 2023

Proxy statement

Apr 28

Annual report to holders ARS

Annual report to holders

Apr 18

Proxy statement PRE 14A

Proxy statement

Apr 5

Earnings call

Q1 2023 earnings call

Apr 5

Current report 8-K

Financial results

Mar 29

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $18.57M ▼ 3.5% Net loss $2.49M Diluted EPS -$0.32

Feb 28

Current report 8-K Events of Feb 23

Director or officer change, or executive pay

Feb 21

Earnings call

Q4 2022 earnings call

Feb 21

Current report 8-K

Financial results

Feb 1

Current report 8-K Events of Jan 24

Director or officer change, or executive pay